Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy. [PDF]
Matteini E +9 more
europepmc +1 more source
Glucocorticoid reduction with baricitinib in rheumatoid arthritis refractory to prior therapies: a 24-week real-world analysis. [PDF]
Yamane T +4 more
europepmc +1 more source
Autoimmune Phenomena and New-Onset Type 1 Diabetes Following SARS-CoV-2 Vaccination: A Personal Perspective. [PDF]
Sugaya K.
europepmc +1 more source
Case Report: A case of autoinflammatory disease with a novel <i>NLRP12</i> variant-clinical presentation and successful treatment with baricitinib. [PDF]
Wang W +7 more
europepmc +1 more source
Primary Biliary Cholangitis With Incomplete Response to Conventional Therapies But Had Complete Response to Baricitinib: A Case Report. [PDF]
Kim GE, Imran M, Mostafa S, Kamel Y.
europepmc +1 more source
Baricitinib in chronic kidney disease: an exploratory analysis integrating network toxicology, molecular docking and pharmacovigilance. [PDF]
Zheng R +9 more
europepmc +1 more source
Reconsidering Efficacy and Safety: A Critical Appraisal of Repurposing Anti-inflammatory Targeted Drugs in Darier disease. [PDF]
Burle E +2 more
europepmc +1 more source
Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. [PDF]
Mandecka A +7 more
europepmc +1 more source
Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database. [PDF]
Kong L, Liu X, Feng Y.
europepmc +1 more source
Efficacy of combined JAK1/2 inhibition and cyclosporine in paediatric-onset Still's disease with lung involvement: a case report. [PDF]
Palmeri S +11 more
europepmc +1 more source

